Daschle withdraws as HHS nom.

Tom Daschle, the much lauded pick for secretary of the U.S. Department of Health and Human Services, announced this afternoon that he'll be withdrawing his nomination in light of tax irregularities that have cropped up during the review. "I will not be the architect of America's health care reform, but I remain one of its most fervent supporters," Daschle said in a statement, according to the linkurl:Washington Post.;http://voices.washingtonpost.com/44/2009/02/03/daschle_withdraws.html News

Written byAlla Katsnelson
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Tom Daschle, the much lauded pick for secretary of the U.S. Department of Health and Human Services, announced this afternoon that he'll be withdrawing his nomination in light of tax irregularities that have cropped up during the review. "I will not be the architect of America's health care reform, but I remain one of its most fervent supporters," Daschle said in a statement, according to the linkurl:Washington Post.;http://voices.washingtonpost.com/44/2009/02/03/daschle_withdraws.html News emerged last week that Daschle owed $140,000 in back taxes on a luxury car and driver provided in 2005 by an investment firm he worked with. His withdrawal comes on the heels of this morning's news that President Barack Obama's nominee for Chief Performance Officer, Nancy Killefer, also has tax no-no's in her past, and will be withdrawing from consideration for the post. Daschle had received praise from many in the biomedical community for his commitment to health care policy and his legislative experience.
**__Related stories:__***linkurl: Science orgs. praise HHS pick;http://www.the-scientist.com/blog/display/55213/
[20th November 2008]*linkurl:Daschle rips Bush on science;http://www.the-scientist.com/article/display/22134/
[23th April 2004]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies